Protocol for assessing feasibility, acceptability and fidelity of screening for antenatal depression (FAFSAD) by midwives in Blantyre District, Malawi by Chipps, Jennifer et al.
STUDY PROTOCOL Open Access
Protocol for assessing feasibility,
acceptability and fidelity of screening for
antenatal depression (FAFSAD) by
midwives in Blantyre District, Malawi
Genesis Chorwe-Sungani1*, Modesta Mwagomba2, Kazione Kulisewa3, Ellen Chirwa1, Diana Jere1 and
Jennifer Chipps4
Abstract
Background: Depression is often underdiagnosed by treating health professionals. This is a situation in Malawi
where there is no routine screening of depression at antenatal clinics. Recently, a Screening Protocol for Antenatal
Depression (SPADe) that can be used by midwives to screen for antenatal depression was developed in Blantyre
District. SPADe proposes multistage screening of antenatal depression by midwives which may enable early
detection and treatment of pregnant women with depression. Proper treatment of antenatal depression can assist
in achieving Sustainable Development Goals (SDGs). However, utilisation of SPADe in clinical practice to screening
for depression in antenatal clinics has not been established yet. Therefore, the primary aim of this study is to assess
feasibility of screening for depression by midwives using SPADe in antenatal clinics in Blantyre District. The
secondary aim was to assess acceptability and fidelity of screening for depression by midwives using SPADe in
antenatal clinics in Blantyre District.
Methods: This will be a feasibility study which will consist of scientific investigations that will support movement of
evidence-based, effective health care approach, SPADe, from the clinical knowledge base into routine use. This
study will consist three phases: phase 1 will introduce SPADe in antenatal clinics in Blantyre District where
screening of depression is almost none existent; phase 2 will implement screening of depression using SPADe in
antenatal clinics in Blantyre District; and phase 3 will evaluate the screening of antenatal depression using SPADe to
establish its feasibility, acceptability and fidelity in antenatal clinics in Blantyre District.
Discussion: This study will establish and document feasibility, acceptability and fidelity of screening for depression
by midwives using SPADe in antenatal clinics in Blantyre District. It is expected that midwives will develop more
confidence in detecting and dealing with antenatal depression. Consequently, there will be increased numbers of
pregnant women detected with depression by midwives and increased accessibility to mental health care by
pregnant women in antenatal clinics.
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Background
Depression is a serious health problem affecting preg-
nant women during all stages of their pregnancy [1]. In
Malawi, major depressive disorders (10.7% to 25.8%) are
prevalent among pregnant women [2, 3]. These figures
fall within prevalence rates range of depressive disorders
during pregnancy (8.3% to 41%) reported in sub-Saharan
Africa [4]. Antenatal depression can lead to adverse ef-
fects on both maternal and foetal well-being [5, 6] and
also result into the poor uptake of antenatal services [7].
Pregnant women with untreated depression have a
higher chance of obstetric complications, premature de-
liveries and low birthweight infants [8]. Furthermore,
antenatal depression is a risk factor for postnatal depres-
sion [9]. This is a cause for public health concern and
necessitates proper screening of antenatal depression so
that women with depressive symptoms are timely identi-
fied and treated. Screening for depression encompasses
the use of instruments for measuring symptoms of de-
pression to identify patients who may have depression
but who have not sought treatment and whose depres-
sion has not already been detected by clinicians [10].
However, midwives do not routinely screen for antenatal
depression considering that they have increased work-
load in local antenatal settings where screening for de-
pression is not a key task. This is contrary to a duty of
midwives which requires of them to screen pregnant
women for various conditions [11] including depression
during antenatal care.
Midwives are expected to routinely screen for depres-
sion in all pregnant women [12] to improve detection of
antenatal depression [13]. The American College of Ob-
stetricians and Gynaecologists recommended that preg-
nant women should be screened for antenatal
depression using a standardised and validated instru-
ment [14]. Screening for depression in antenatal clinics
can be done in stages whereby various instruments are
combined [15]. Screening in stages may involve a two-
step process where a short screening instrument is used
to identify potential cases and, for those who screen
positive, a second, often more detailed instrument with
greater specificity, is used to confirm the diagnosis [16].
This is in agreement with Chorwe-Sungani [17] who
proposed that screening of depression in antenatal
clinics in Blantyre District can be implemented using a
Screening Protocol for Antenatal Depression (SPADe).
The SPADe recommends the use of a two-step process
whereby the 3-item screener (ultra-brief instrument)
should initially be used by midwives to identify potential
depression cases followed by Self Reporting Question-
naire (SRQ) 20 to confirm the cases and later a gold
standard administered by a mental health specialist to
confirm a diagnosis [15]. This is supported by Whooley
[18] who asserted that any positive screen result on an
ultra-brief instrument must be followed by a clinical
interview to confirm the presence of depression. Mid-
wives can be able to screen for depression and refer
pregnant women appropriately after receiving some
training [19]. However, midwives may consider screen-
ing for antenatal depression to be too demanding and
requiring too much effort, and this may result in a de-
creased frequency of screening [20]. Midwives may also
have limited knowledge and skills for detecting and
treating mental disorders [5] including antenatal
depression.
Working from the premise that midwives may be
trained to screen and refer antenatal depression cases in
low-resource settings [19], it is important that midwives
in local antenatal clinics are trained on the use of
SPADe. This may help midwives to integrate screening
of depression into antenatal services [21] and provide ef-
fective mental health care in an organised manner [22].
Nonetheless, what remains unknown is acceptability,
feasibility and fidelity of screening for depression by
midwives using SPADe in antenatal clinics in Blantyre
District.
Rationale for the research project
The Lancet series on maternal mental health have recog-
nised the clinical and public health importance of ante-
natal depression [8, 23–25]. Prevalence of antenatal
depression is high [23] and is linked with adverse child
outcomes in low resource settings where pregnant
women have increased exposure to risk factors of de-
pression [26]. The adverse mental health outcomes for
the child include an increased risk of anxiety, depression,
attention deficit hyperactivity disorder and conduct dis-
order [26]. It is documented that pregnant women with
untreated depression have a higher likelihood of obstet-
ric complications, premature deliveries and low birth-
weight infants [8]. This may be the case in Malawi
where obstetric complications are common and many
babies with low birthweight are born.
Apart from the aforementioned adverse effects, ante-
natal depression and HIV infection form a vicious cycle,
whereby the symptoms of each disease worsen the status
of the other, and each needs to be sufficiently treated for
the pregnant woman to become healthy [24]. It is of
public health concern that pregnant women with co-
morbidity of depression and HIV infection are less likely
to adhere to antiretroviral therapy, which is critical for
her survival and prevention of HIV transmission to the
newborn [25]. Stringer and colleagues [24] recom-
mended integration depression-screening technique in
antenatal services that could identify a large proportion
of affected women to break the cycle of depression and
HIV infection interaction. It is documented that inte-
grating mental health services into primary care may be
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the most viable way of closing treatment gap for mental
health in low resource settings [23] in order to achieve
the United Nations Sustainable Development Goals
(SDGs). An important step in this direction is the in-
corporation of the capacity to prevent, recognise and
treat depression within antenatal care [27]. This may
help to meet the immediate mental health needs of a
pregnant woman, ensure better maternal and child out-
comes and contribute towards the success of HIV/AIDS
services [24].
Integrated antenatal services aimed at identifying and
treating women with antenatal depression are needed
because antenatal care is typically the first and only time
of interaction with the health care system for many
women in low resource settings [23]. As such, antenatal
care visits provide critically important opportunities for
mental health interventions to occur. But antenatal de-
pression is often underdiagnosed by midwives because
there are no depression screening instruments at ante-
natal clinics in Malawi [15]. Nonetheless, a previous
study proposed SPADe, a locally developed protocol as
suitable for screening depression among pregnant
women in antenatal clinics in Blantyre District [17]. It is
documented that locally developed protocols may be
more acceptable to clinicians and consequently more
likely to be adopted and used in practice [28]. However,
utilisation of SPADe in clinical practice to implement
screening of depression in antenatal clinics has never
been tested before.
Therefore, the primary aim of this study is to assess
the feasibility of screening for depression by midwives
using SPADe in antenatal clinics in Blantyre District.
The secondary aim was to assess acceptability and fidel-
ity of screening for depression by midwives using SPADe
in antenatal clinics in Blantyre District. In this study, ac-
ceptability refers to what extent is a new idea,
programme, process or measure judged as suitable, satis-
fying or attractive to programme deliverers or
programme recipients [29] while feasibility means deter-
mining whether an intervention can be shaped to be
relevant and sustainable by identifying what aspects need
modification and how changes might occur [29]. Fur-
thermore, fidelity of treatment refers to the confirmation
that the manipulation of the independent variable oc-
curred as planned to ensure that fair, powerful and valid
comparisons of replicable treatments can be made [30].
Conceptual model
This study will draw on a Conceptual Model of Imple-
mentation Research (CMIR) by Proctor and colleagues
[31] as its underpinning (Fig. 1). The major concepts of
CMIR are implementation strategies and outcomes
which are linked. The model proposes evidence-based
intervention strategies and separate strategies for imple-
menting those interventions in usual care. Furthermore,
the CMIR proposes three distinct but interrelated types
of outcomes namely: implementation, service and client
outcomes. It also allows for involvement of multiple
Fig. 1 Conceptual model of implementation research. Adapted from Proctor et al. (2009) [31]
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stakeholders at multiple levels of implementation pro-
cesses. The CMIR recommends that a relationship be-
tween intervention strategies and implementation
strategies should be empirically tested because various
intervention strategies encounter unique implementation
challenges.
Application of conceptual model to the study
Antenatal depression is often underdiagnosed by mid-
wives because there are no depression screening instru-
ments at antenatal clinics in Blantyre District in Malawi
[15]. In this study, an implementation strategy for
screening antenatal depression (SPADe) by midwives
will be tested in three antenatal clinics in Blantyre Dis-
trict [17]. This study will use clinician implementation
team strategy by Proctor and colleagues [32] that will
utilise a team of midwives (actor) to implement SPADe,
a clinical innovation. It will involve (action) reflecting on
the implementation effort, sharing of lessons learned,
support learning and proposition of changes to be im-
plemented. The targets of the action will be midwives
that will be newly trained in screening for antenatal de-
pression using SPADe. Midwives will be equipped with
knowledge about how to use the SPADe to screen for
depression in antenatal clinics and collaborate effectively
with mental health specialists so that pregnant women
are able to access mental health care within antenatal
clinics. The research team will meet the midwives for
the first time to facilitate the commencement of screen-
ing for depression in antenatal clinics within 2 weeks of
initial training (temporality). Then, the research team
will go to antenatal clinics once fortnightly for 4 h for
the 4 months (dose) to conduct supportive supervision
to the midwives. This will be done to facilitate uptake of
screening using SPADe among pregnant women, ensure
that midwives are implementing SPADe faithfully and
ensure its sustainability (implementation outcome). The
proposed clinician implementation team strategy is rele-
vant for this study because it will enhance cooperative
learning among midwives and the researchers [33].
The implementation outcomes for this study will en-
compass feasibility, acceptability and fidelity of utilising
SPADe in screening for antenatal depression. The ser-
vice outcomes for this study will be twofold: (1) early, ef-
fective and increased detection of antenatal depression
and (2) effective treatment and referrals of pregnant
women with antenatal depression. The service provider’s
outcome that will be measured in this study will be mid-
wives’ satisfaction, competence and commitment in
screening of antenatal depression.
Methods
This study will be an implementation research which
will consist of scientific investigations that will support
the movement of evidence-based, effective health care
approach, SPADe, from the clinical knowledge base into
routine use [31]. This study will employ multi-methods to
assess the feasibility, acceptability and fidelity of screening
for antenatal depression using SPADe in three phases:
phase 1 will introduce SPADe in antenatal clinics in Blan-
tyre District where screening of depression almost none
existent; phase 2 will implement screening of depression
using SPADe in antenatal clinics in Blantyre District; and
phase 3 will evaluate the screening of antenatal depression
using SPADe to establish its feasibility, acceptability and
fidelity in antenatal clinics in Blantyre District.
Phase 1: Introducing of screening for antenatal
depression using SPADe
Setting for the study
The study setting will be Blantyre District in Malawi and
includes the antenatal clinics of the following health cen-
tres: Chileka, Mpemba and Ndirande. These are govern-
ment health facilities which provide free health care
services to the majority of people in rural and urban
areas of Blantyre District. Midwives run antenatal clinics
at these health facilities. The clinics are conducted dur-
ing morning hours from Monday to Friday every week.
These settings are suitable for this study because they
have established antenatal clinics where pregnant
women can be easily accessed. The three antenatal
clinics are included in this study because they previously
contributed data that informed development of SPADe
[17]. The antenatal attendance of pregnant women at
these health facilities for the period June 2018 to July
2019 ranged from 1292 to 11,498.
Study population
The target population will include all midwives working
in antenatal clinics at Chileka (21), Mpemba (15) and
Ndirande Health Centres (26) making a total of 62 mid-
wives. All 62 midwives will participate in this study.
Process of introducing screening of antenatal depression
using SPADe
The study will be conducted from July 2020 to March
2020. Prior to introduction of screening for antenatal de-
pression using SPADe in antenatal clinics, the PI will
hold four meetings with Leadership at District Health
Office level (1) and Health Centre Level (3) in July 2020.
The meetings will aim at orienting the leaders about the
study and also seek their buy-in. In this study, the
screening of antenatal depression by midwives using
SPADe will be introduced in the three aforementioned
health centres. The researcher will explain the study to
all midwives and invite them to participate in this study
before the commencement of training. Those who will
accept to participate will give a written consent. The
Chorwe-Sungani et al. Pilot and Feasibility Studies            (2021) 7:32 Page 4 of 11
midwives will implement screening of antenatal depres-
sion and referrals after receiving training on the use of
SPADe [17]
In August 2020, the PI, an Advanced Practice Mental
Health Nurse, with the help of collaborators will train all
midwives (62) in the three health centres in screening of
antenatal depression using SPADe. In addition, 4 mental
health nurses from Queen Elizabeth Central Hospital
will also participate in this training resulting in a total of
66 participants. Two training sessions for the trainer of
trainers will be conducted within Blantyre for 3 days and
will involve one day for theory and 2 days for practice at
one antenatal clinic to create a critical mass. Each train-
ing will include half of the midwives from each health
centre. This would allow midwives to participate in the
training without disrupting the delivery of services in
these facilities.
Prior to the training, all participants will be asked to
answer a pre-test questionnaire (baseline) on their com-
mitment and competency in screening for antenatal de-
pression including the support they receive (Additional
file 1), and it will be repeated at the end of the training
(post-test). These trained midwives will be expected to
train on the job new staff about screening of antenatal
depression using SPADe training materials as a way of
realising a multiplier effect. During the practical sessions
of training, midwives will be supervised by the PI and
collaborators.
All midwives (62) will be required to use SPADe to
screen for antenatal depression and determine a need
for treatment or referral among pregnant women. The
SPADe is specifically designed for pregnant women with
depression, and it is not intended to cover the whole
spectrum of pregnant women with other mental disor-
ders. This screening protocol focuses on improving the
quality and accessibility of maternal mental health care
by integrating routine screening for depression into
antenatal services so that pregnant women with, or at
risk of, depression are timeously detected and the appro-
priate treatment can commence. The SPADe is intended
to reflect optimum practice in routine screening for de-
pression and the management of pregnant women at
risk or with depression in antenatal clinics in Malawi.
The components of the SPADe include antenatal ser-
vices and antenatal care assessment, midwives’ functions,
screening instruments and mental health assessment. It
also includes an algorithm which outlines steps for
screening and treatment pathways (Additional file 2).
After completing all training sessions in August 2020, all
the trained midwives from the three health centres will
be equipped with materials to start screening for depres-
sion using SPADe. They will also be charged with the re-
sponsibility of teaching new staff in the antenatal clinics
on how they can effectively screen in their settings.
Phase 2: Implementation of screening for depression
using SPADe in antenatal clinics
In September 2020, the three health centres will prepare
to implement screening of antenatal depression using
SPADe. Meetings will be held with leadership at the fa-
cilities, midwives and mental health nurses to integrate
the screening of depression in their local antenatal
clinics. From September to December 2020, screening of
antenatal depression using SPADe will be launched in
the three health centres. Pregnant women at any stage of
gestation will be screened for depression at the initial
booking at the antenatal clinic.
Midwives will initially administer the 3-Item Screener
[15, 17] to pregnant women during history taking (Add-
itional file 3) and those who will screen positive on the
3-Item Screener will be interviewed further using Self
Reporting Questionnaire (SRQ) 20 (Additional file 3)
immediately [15, 17]. Pregnant women who will screen
positive on SRQ 20 will be further interviewed by the PI
or a mental health nurse to confirm the presence of
major depressive episode on the same day using the
major depression module of the Mini International
Neuropsychiatric Interview (MINI) [34]. The PI and vis-
iting mental health nurses will also provide therapy (an-
tidepressants and psychosocial counselling) to all
pregnant women confirmed as having depression in ac-
cordance with SPADe and Malawi Standard Treatment
Guidelines [35].
During the entire implementation period of screening
for depression, midwives will be receiving support in
terms of continuous supervision from the PI, collabora-
tors and 4 visiting mental health nurses from Queen
Elizabeth Central Hospital Psychiatric Unit. A focal per-
son for screening of antenatal depression using SPADe
(midwife in charge of the antenatal clinic) in each clinic
will be providing feedback on screening rates at staff
meetings and via posters and relevant Health Manage-
ment Information System (HMIS) registers.
Measuring feasibility, acceptability and fidelity of
screening for depression among midwives
This will be both a quantitative and qualitative survey
that will be conducted in antenatal clinics at Chileka,
Mpemba and Ndirande Health Centres. The study sam-
ple will include all 62 midwives who would have re-
ceived training in screening using SPADe and will be
participating in screening for antenatal depression (Chi-
leka = 21, Mpemba = 15 and Ndirande = 26) will be sur-
veyed three times between September and December
2020. The surveys will focus on measuring feasibility, ac-
ceptability and fidelity of screening for depression using
SPADe.
The PI with the help of two research assistants (Regis-
tered Midwives) will collect data from midwives. Prior to
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data collection, the research assistants will receive two
days training that will include an overview of the re-
search study, review of data collection techniques and
instruments, practice on the use of data collection in-
struments and a discussion on ethical issues pertaining
to the study. The PI and a research assistant will hand a
self-administered semi-structured questionnaire to each
respondent and ask them to answer it immediately. The
PI and research assistant will collect all completed ques-
tionnaires immediately after they have been completed.
Measuring feasibility of using SPADe by midwives
The adapted Structured Assessment of FEasibility
(SAFE) Version 1.1 [36] will be used to assess the extent
to which SPADe is feasible for implementation in ante-
natal clinics. Midwives will be asked to indicate their
level of agreement with each of the 16 statements by
choosing one of the following possible responses: yes,
partial, no or unable to rate (Additional file 4). Exactly
one rating is made for each item. It is recommended
that no overall summary score is used, as barriers and
facilitators differ in their importance depending on the
context.
A prospective questionnaire to assess feasibility of the
SPADe among 62 midwives at the three selected health
centres in Blantyre District will be administered to par-
ticipants. This study will use census (62 midwives) be-
cause all midwives rotate in antenatal clinics in all health
centres. They will anonymously complete the instrument
(SAFE) at three evaluation moments during SPADe im-
plementation period, September 2020 to December
2020. The implementation process of SPADe will be
continuously updated by posters and supervision. We
will assess feasibility of the SPADe at the beginning of
the implementation of screening in September 2020 and
the second moment will be halfway the implementation
(end October 2020) and the last moment will be at the
end of the implementation of screening (December
2020). As feasibility outcomes, we expect that (1) ≥80%
of participants will be participating in screening for ante-
natal depression and (2) increase in the number of preg-
nant women detected with depression in antenatal
clinics by December 2020. The following criteria will be
used to determine the success of feasibility: (1) ongoing
supportive supervision by mental health nurses will be
provided to midwives in antenatal clinics regularly dur-
ing the implementation of SPADe and (2) the full
SPADe manual will be available from the corresponding
author. We will compute descriptive statistics for bar-
riers and enablers for the implementation of SPADe at
three points of data collection. Cross tabulations will be
used to compare barriers and enablers for the imple-
mentation of SPADe that will be identified at three
points of data collection. To evaluate feasibility of using
SPADe for screening antenatal depression, the primary
outcome measures will be (1) percentage of midwives (≥
80%) who will participate in screening by December
2020 and (2) increase in percentage (from 0%) of preg-
nant women detected with depression by midwives. All
measures will be assessed at each time point. The indi-
vidual's midwife 3 ratings of the feasibility questionnaire
will be analysed separately from the collective set of data
that will be collected for the general attitude of midwives
assess their change in attitude while gaining more confi-
dence in implementing the screening protocol between
September and December.
Measuring acceptability of using SPADe by midwives
The Ottawa Acceptability of Decision Rules Instrument
(OADRI) that was designed to measure the acceptability
of clinical decision rules will be used to assess accept-
ability of SPADe [37]. Midwives will be asked to indicate
their level of agreement with each of the 12 statements
on a 6-point scale ranging from 1 (strongly disagree) to
6 (strongly agree), or indicating ‘no opinion/don’t know’
(Additional file 4). The first 7 items have been phrased
such that a higher number indicated greater acceptability
while the last 5 have been phrased so that a higher num-
ber indicated less acceptability. The final total score of
the instrument will consist of the average of all 12 items
(ranging from 0 to 6). Non-completed items will be ex-
cluded from the final total scores. The average of the
remaining items will serve as the instrument’s score.
Midwives who will complete less than 8 of the 12 items
will be considered as not having completed the instru-
ment and will be excluded from the final analyses. Items
for which ‘no opinion/don’t know’ was selected will be
coded as the middle of the scale [37].
A prospective questionnaire evaluation among 62 mid-
wives at the three selected health centres in Blantyre
District will be conducted. They will anonymously
complete the instrument (OADRI) at three evaluation
moments during SPADe implementation period, Sep-
tember 2020 to December 2020. The implementation
process of SPADe will be continuously updated by post-
ers and supervision. The first evaluation moment will
take place at the beginning of the implementation of
screening in September 2020 and the second moment
will be halfway the implementation (end October 2020)
and the last moment will be at the end of the implemen-
tation of screening (December 2020).
We will calculate average item scores and greater ac-
ceptability will be indicated by higher scores. To test dif-
ferences between the item scores of the OADRI during
the three moments of the screening implementation, we
will use linear regression analyses. We will test changes
in average item scores within the suggested original cat-
egories of OADRI items [37]: (1) aspects of innovation,
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items 1–4; (2) decision-maker, items 6–9 and 11; and (3)
environment, items 5, 10, and 12. The individual’s mid-
wife 3 ratings of the acceptability questionnaire will be
analysed separately from the collective set of data that
will be collected for the general attitude of midwives as-
sess their change in attitude while gaining more confi-
dence in implementing the screening protocol between
September and December.
Measuring fidelity of using SPADe by midwives
At the start of the project, all midwives (62) will be
trained in the implementation of SPADe in a three days
training that will include a practical component. They
will receive biweekly supervision from a mental health
specialist at antenatal clinics that will be implementing
SPADe. A refresher training for all midwives (62) will
take place at the midpoint (end October 2020) of imple-
menting SPADe.
A prospective evaluation of fidelity in using SPADe
among 62 midwives will be conducted using a question-
naire that has been adapted from Bellg and colleagues [38]
recommendations for enhancing treatment fidelity in be-
haviour change studies (Additional file 5). These recom-
mendations include study design, training providers,
delivery of treatment, receipt of treatment and enactment
of treatment skills [38]. This study will focus on two rec-
ommendations namely: training providers and delivery of
treatment because the other three are beyond the scope of
this study. Training of providers is an important area of fi-
delity that will be assessed to ensure that midwives have
been satisfactorily trained to implement SPADe with preg-
nant women. Literature suggests that the adequacy of
training to implement an intervention should be evaluated
and monitored on an individual basis both during and
after the training process [38]. Delivery of treatment will
focus on treatment fidelity processes that will monitor and
improve implementation of SPADe so that it is delivered
as intended. It is documented that even well-trained inter-
ventionists may not always deliver an intervention proto-
col effectively when clinical circumstances or their
training or involvement in other types of interventions
interfere with their doing so [38]. The goal will be to
check for midwives’ adherence to implementation of
SPADe in clinical practice as intended.
Midwives will anonymously complete the question-
naire at the beginning of the implementation of screen-
ing in September 2020 and the second moment will be
halfway the implementation (end October 2020) and the
last moment will be at the end of the implementation of
screening (December 2020). Furthermore, the re-
searchers will do the following to assess fidelity:
a. Fidelity strategies for monitoring and improving
midwives training
The researchers will keep field notes about the training
that midwives will receive prior to the implementation
of SPADe. The field notes will check and confirm if the
training will be conducted as described in this section:
i. The study will use a standardized training to equip
all midwives with knowledge and skills for using
SPADe in screening antenatal depression.
ii. All the 62 midwives will receive the same training
in screening using SPADe together.
iii. A standardised SPADe training manual will be used
during training.
iv. SPADe training will accommodate midwives of
different cadres regardless of their different levels of
experience.
v. Midwives will be involved in structured practice
and role-playing during SPADe training
vi. Standardised pregnant women will be used during
SPADe training.
vii. These midwives will have an opportunity to observe
SPADe implementation with standardised pregnant
women.
viii.Same instructors will be used to train all midwives
ix. SPADe training will be videotaped in case there
would be a need for future training for other
midwives.
The study will ensure midwives’ skill acquisition by asses-
sing midwives’ adherence to screening using SPADe by:
i. Using a skills acquisition checklist (Additional file 6).
ii. Midwives writing an exam pre- and post-SPADe
training (Additional file 1).
The researchers will minimise ‘drift’ in midwives’ skills
will by:
i. Conducting regular booster sessions about SPADe
with midwives
ii. Conducting weekly supervisions and periodic
meetings on screening using SPADe
iii. Allowing easy access to project staff to ask
questions about screening using SPADe
iv. Keeping field notes about booster sessions,
supervisions, meetings and availability of project
staff to midwives
v. Having midwives complete self-report question-
naires to evaluate the use of SPADe at the end of
the study (Additional file 5).
b. Fidelity strategies for monitoring and improving the
implementation of SPADe
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Researchers will control provider differences by:
i. Ensuring that midwives are screening all pregnant
women using SPADe without being selective and
field notes will be recorded.
ii. Conducting a qualitative and quantitative survey at
the end of the study (Additional file 5).
Researchers will reduce differences within the screen-
ing process by:
i. Providing a scripted SPADe to all midwives that
will be used by during screening of pregnant
women
ii. Audio or video recording all encounters with
midwives to ensure adherence to SPADe
iii. Checking errors of omission and commission in the
implementation of SPADe which will be recorded
as field notes.
We will compute descriptive quantitative data and
content analysis will be used to analyse qualitative data
about fidelity in implementation of SPADe in antenatal
clinics. The researchers will rate audio/video clips on
their encounter with midwives or screening sessions
conducted by midwives using a checklist (Additional file
6)
Phase 3: Evaluation of screening for antenatal depression
using SPADe
In December 2020, 4 months after implementing screen-
ing of antenatal depression using SPADe, a multi-
methods evaluation (quantitative and qualitative survey)
of the programme will be conducted. Midwives will be
asked about their views on screening of antenatal de-
pression using SPADe and how they accomplished this
task, and screening rates and how many women were
identified as possibly depressed will be determined. The
evaluation will focus on feasibility, acceptability and fi-
delity of screening for antenatal depression using SPADe
among midwives.
This will be a quantitative and qualitative survey.
Quantitative data will be used to evaluate implementa-
tion outcomes of screening antenatal depression and
qualitative data to evaluate the process of implementing
depression screening using SPADe [39]. Furthermore,
qualitative data will be used to provide a depth of under-
standing about screening of antenatal depression and
quantitative data will provide a breadth of understanding
about screening for antenatal depression. This study will
use all 62 midwives who would have received training in
screening using SPADe and would have been working in
antenatal clinics during the study period. The instru-
ment that will be used to collect data in this study was
developed by the PI by adopting and adapting questions
that were previously used by other researchers to assess
acceptability, feasibility and fidelity of screening depres-
sion [40] or other conditions among health professionals
[41] (Additional file 5). The instrument will be a self-
administered semi-structured questionnaire that will be
used to assess how midwives viewed the implementation
of depression screening in antenatal clinics. The instru-
ment will include both closed questions (1–7, 10–11)
and directive free-text questions (8–9, 12–19) (Add-
itional file 5). Directive free-text questions will be an ap-
propriate method for gathering the opinions of
contextual issues that are considered pertinent by re-
spondents of a survey [42, 43]. These questions will en-
able midwives to express their opinions and provide
useful contextual information at the time the survey will
be administered [44]. The instrument will be in English
because all midwives are expected to be conversant with
English by virtue of their training.
The PI with the help of a research assistant will con-
duct two data collection sessions within Blantyre District
in December 2020. A total of 31 midwives (Chileka = 11,
Mpemba = 7 and Ndirande = 13) will be invited to the
first data collection session. Then, 2 days later, a second
group of 31 midwives (Chileka = 10, Mpemba = 8 and
Ndirande = 13) will also be called to a data collection
session within Blantyre District as well. These midwives
who will participate in screening for depression will re-
spond to a survey at the end of 4 months period. The PI
and a research assistant will hand a self-administered
semi-structured questionnaire to each respondent and
ask them to answer it right there without consulting
others. The PI and research assistant will collect all com-
pleted questionnaires before respondents leave the meet-
ing room. Finally, the PI will thank all respondents for
taking part in the study.
This study will adopt recommendations for reporting
free-text comments that will involve reporting the mini-
mum and maximum length of sentences made by partici-
pants, the number of participants who will make comments
within each theme and the number of participants who will
fail to make any free-text responses [45, 46]. Content ana-
lysis will be used to analyse free-text comments [47, 48].
The comments will be read multiple times in order to gain
immersion in the data. Content-characteristic words in
free-text comments will be identified and free-text com-
ments sorted into categories, from which emergent themes
will be identified. Exemplar comments with the descriptive
text accompanying each theme will be used in content ana-
lysis [47]. The data analysis will also include a quantitative
summary of the themes encompassing the midwives’
responses.
Quantitative data will be analysed using Statistical
Package for Social Sciences (SPSS) 25 with the help of a
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statistician. Descriptive statistics including means, stand-
ard deviations, percentages and frequencies will be used
to summarise data. Potential differences in demographic
characteristics will be examined using Pearson’s chi-
squared test and statistical significance level will be set
at P < 0.05 with 95% confidence interval. Binary logistic
regression models will be used to generate factors asso-
ciated with feasibility and acceptability of screening for
depression using SPADe.
Ethical considerations
The study proposal received ethics approval from the
College of Medicine Research and Ethics Committee
(COMREC) at the University of Malawi (P.02/20/2935).
The PI and research assistant will explain the nature and
benefits of the study to pregnant women and midwives
before they are recruited to participate in the study.
They will ensure that they minimise harm to pregnant
women and midwives who will participate in this study.
Participants’ names will not form part of demographic
data that will be collected, thus respecting their privacy
and maintaining confidentiality. Midwives will be in-
formed that they will be offered Malawi Kwacha equiva-
lent of $10.00 (K7 500.00) for participating in the study.
Furthermore, they will be informed that the information
which they will provide will be utilised in making recom-
mendations about maternal mental health care targeting
pregnant women. Participants will be informed that only
aggregated data will be analysed and disseminated. They
will also be informed that all hard copies of data col-
lected will be locked in a cabinet of the PI at Kamuzu
College of Nursing and will be incinerated after 5 years.
As for electronic data, it will be secured by a password
known only to the researcher and would be deleted from
the storage device after 5 years.
Midwives will be informed that their participation in
the study is voluntary and those who accept to partici-
pate will be asked to give a written informed consent.
They will be told that they will be free to withdraw at
any time if they felt uncomfortable about any aspect
during the course of the study. As such, evaluation of
screening for antenatal depression using SPADe will
only include data collected from midwives who will par-
ticipate in the actual implementation of SPADe in ante-
natal clinics. They will also be told that refusing to join
the study will not have any effect on their job because
the PI is not an employee of the Ministry of Health.
Discussions
This study will establish and document feasibility, ac-
ceptability and fidelity of screening for depression by
midwives using SPADe in antenatal clinics in Blantyre
District. It is expected that midwives will develop more
confidence in detecting and dealing with antenatal
depression. Consequently, there will be increased num-
bers of pregnant women detected with depression by
midwives and increased accessibility to mental health
care by pregnant women in antenatal clinics. A limita-
tion of this study is that it will be conducted in Blantyre
District only which may not be representative of Malawi
cultures. However, Blantyre has both rural and urban
settings such that it has features of rural and urban dis-
tricts in Malawi. Midwives may feel overwhelmed with
the task of screening for depression. However, this chal-
lenge will be lessened by using mental health nurses to
provide treatment to pregnant women with depression.
Midwives will also be assisted through continuous sup-
portive supervision throughout the study period. The
study design is also limited because screening of women
at the initial booking only will not allow pregnant
women who will screen ‘negative’ for depression to have
another chance to screen ‘positive’ in subsequent visits if
they were to develop depression later. Furthermore, it
would also be hard for midwives to re-screen ‘negative’
cases in subsequent visits as this will be a new task for
them. This will probably affect midwives’ feasibility
scores and validity of the study because midwives may
be required to re-screen ‘negative’ patients in subsequent
visits in real life.
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